Mwanzo600276 β’ SHA
add
Jiangsu Hengrui Pharmaceuticals Co Ltd
Bei iliyotangulia
Β₯Β 64.27
Bei za siku
Β₯Β 63.68 - Β₯Β 66.42
Bei za mwaka
Β₯Β 42.40 - Β₯Β 74.04
Thamani ya kampuni katika soko
409.98B CNY
Wastani wa hisa zilizouzwa
74.05M
Uwiano wa bei na mapato
57.09
Mgao wa faida
0.30%
Ubadilishanaji wa msingi
SHA
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 8.56B | 12.53% |
Matumizi ya uendeshaji wa biashara | 4.88B | 7.13% |
Mapato halisi | 2.58B | 24.88% |
Kiwango cha faida halisi | 30.11 | 10.98% |
Mapato kwa kila hisa | β | β |
EBITDA | 2.82B | 22.24% |
Asilimia ya kodi ya mapato | 13.35% | β |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 36.23B | 55.59% |
Jumla ya mali | 62.89B | 30.53% |
Jumla ya dhima | 3.86B | -22.64% |
Jumla ya hisa | 59.03B | β |
hisa zilizosalia | 6.47B | β |
Uwiano wa bei na thamani | 7.11 | β |
Faida inayotokana na mali | 11.49% | β |
Faida inayotokana mtaji | 12.29% | β |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 2.58B | 24.88% |
Pesa kutokana na shughuli | 3.75B | 110.63% |
Pesa kutokana na uwekezaji | -553.06M | 28.47% |
Pesa kutokana na ufadhili | 8.70B | 7,324.40% |
Mabadiliko halisi ya pesa taslimu | 11.91B | 1,228.08% |
Mtiririko huru wa pesa | 3.01B | 6.79% |
Kuhusu
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China. Wikipedia
Ilianzishwa
28 Apr 1997
Tovuti
Wafanyakazi
20,560
